SIM
OVID icon

Spark Investment Management’s Ovid Therapeutics OVID Stock Holding History

Spark Investment Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5K Buy
+31,800
New +$82.1K 0.17% 50
2018
Q4 		– Sell
-13,800
Closed -$78K – 768
2018
Q3 		$78K Buy
+13,800
New +$105K ﹤0.01% 622
2018
Q2 		– Sell
-19,800
Closed -$139K – 709
2018
Q1 		$139K Buy
19,800
+9,000
+83% +$72.8K 0.01% 534
2017
Q4 		$106K Buy
+10,800
New +$99.2K 0.01% 617

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Spark Investment Management's OVID Position: Q2 2026 in Review

Spark Investment Management opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 31,800 shares worth $85.5K. The stake represents 0.17% of the portfolio and ranks #50 among its holdings. This is a return to the name: Spark Investment Management previously reported a position in OVID as recently as Q3 2018.

Spark Investment Management first reported a position in OVID in Q4 2017 and has held it in 4 quarters since. The position peaked at $139K in Q1 2018. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Spark Investment Management held 31,800 shares of Ovid Therapeutics worth $85.5K as of Q2 2026.
  • Ovid Therapeutics was a new Spark Investment Management position in Q2 2026.
  • Ovid Therapeutics made up 0.17% of Spark Investment Management's portfolio in Q2 2026, its #50 holding.
  • Spark Investment Management first reported a position in Ovid Therapeutics in Q4 2017 and has held it in 4 quarters since.
  • Spark Investment Management's Ovid Therapeutics position peaked at $139K in Q1 2018.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Spark Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.